Kelly R. Thornburg
Corporate Officer/Principal bij CHIMERIC THERAPEUTICS LIMITED
Profiel
Kelly R.
Thornburg is currently the Vice President & Head-Quality at Chimeric Therapeutics Ltd.
(Australia) since 2022.
Previously, Thornburg worked as an Executive Director-Quality at Amgen, Inc. and as the Head-US Commercial Manufacturing at Kite Pharma, Inc. Thornburg also served as the Senior Vice President-Operations at XBiotech, Inc. from 2015 to 2017.
Thornburg obtained an undergraduate degree from Rockhurst University.
Actieve functies van Kelly R. Thornburg
| Bedrijven | Functie | Begin |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Corporate Officer/Principal | 03-02-2022 |
Eerdere bekende functies van Kelly R. Thornburg
| Bedrijven | Functie | Einde |
|---|---|---|
| XBIOTECH INC. | Operationeel Directeur | 05-05-2017 |
| KITE PHARMA INC | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Opleiding van Kelly R. Thornburg
| Rockhurst University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| XBIOTECH INC. | Health Technology |
| AMGEN INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
